Millipore Sigma Vibrant Logo

504368 O-1602 - CAS 317321-41-8 - Calbiochem

504368
  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited Availability
Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

       

      Contact Customer Service

      Overview

      Replacement Information

      Key Spec Table

      CAS #Empirical Formula
      317321-41-8C₁₇H₂₂O₂
      Description
      Overview

      This product has been discontinued.



      A potent agonist for the putative cannabinoid receptor, G protein-coupled receptor 55 (GPR55 receptor) (EC50 = 13 nM). Does not activate either CB1 or CB2 receptors (EC50 > 30000 nM for both CB1 and CB2 receptors) and does not elicit any psychotropic activity.

      Catalogue Number504368
      Brand Family Calbiochem®
      Synonyms5-Methyl-4-[(1R,6R)-3-methyl-6-(1-cyclohexen-1-yl]-1,3-benzenediol
      References
      ReferencesJohns,D., et al. 2007. Br. J. Pharmacol. 152, 825.
      Ryberg, E., et al. 2007. Br. J. Pharmacol. 152, 1092.
      Product Information
      CAS number317321-41-8
      FormLiquid
      FormulationSupplied as a solution in methyl acetate.
      Hill FormulaC₁₇H₂₂O₂
      Chemical formulaC₁₇H₂₂O₂
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetGPR55 cannabinoid receptor
      Purity≥99% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      504368 0

      Documentation

      O-1602 - CAS 317321-41-8 - Calbiochem MSDS

      Title

      Safety Data Sheet (SDS) 

      References

      Reference overview
      Johns,D., et al. 2007. Br. J. Pharmacol. 152, 825.
      Ryberg, E., et al. 2007. Br. J. Pharmacol. 152, 1092.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision17-July-2013 JSW
      Synonyms5-Methyl-4-[(1R,6R)-3-methyl-6-(1-cyclohexen-1-yl]-1,3-benzenediol
      DescriptionA potent agonist for the putative cannabinoid receptor, G protein-coupled receptor 55 (GPR55 receptor) (EC50 = 13 nM). Does not activate either CB1 or CB2 receptors (EC50 > 30000 nM for both CB1 and CB2 receptors) and does not elicit any psychotropic activity.
      FormLiquid
      FormulationSupplied as a solution in methyl acetate.
      Intert gas (Yes/No) Packaged under inert gas
      CAS number317321-41-8
      Chemical formulaC₁₇H₂₂O₂
      Structure formulaStructure formula
      Purity≥99% by HPLC
      SolubilityDMSO (30 mg/ml)
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesJohns,D., et al. 2007. Br. J. Pharmacol. 152, 825.
      Ryberg, E., et al. 2007. Br. J. Pharmacol. 152, 1092.